D
Neogenomics, Inc. NEO
$11.38 $0.211.88% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$11.17
Volume
2,620,739
Avg Vol (90D)
2,625,824
Market Cap
$1.45B
Dividend & Yield
--
52-Week Range
$4.72 - $14.73
P/E (TTM)
--
EPS (TTM)
-$0.89
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3 Hot Trades for Insiders, But Are They Good Buys for Investors?
6/24/2025 - MarketBeat
A Look At NeoGenomics (NEO) Valuation After The Launch Of PanTracer Pro In Precision Oncology
2/14/2026 - Simply Wall St
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
2/12/2026 - Business Wire
1 Stock Under $50 Worth Your Attention and 2 We Brush Off
2/9/2026 - StockStory Articles
NeoGenomics (NEO, $11.41) RSI Indicator left the oversold zone on February 06, 2026
2/7/2026 - Tickeron - Stocks
NeoGenomics (NEO, $11.27) RSI Indicator left the oversold zone on February 05, 2026
2/6/2026 - Tickeron - Technical Analysis
NeoGenomics (NEO, $11.27) price may climb as it broke lower Bollinger Band on Feb 05, 2026
2/6/2026 - Tickeron - Technical Analysis
NeoGenomics (NEO, $11.97) price exceeded its 50-day Moving Average on February 04, 2026
2/5/2026 - Tickeron - Stocks
165,890 Shares in NeoGenomics, Inc. $NEO Purchased by Y Intercept Hong Kong Ltd
2/1/2026 - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Receives $12.00 Consensus Target Price from Brokerages
2/1/2026 - Ticker Report
NeoGenomics (NEO, $12.06) price exceeded its 50-day Moving Average on January 30, 2026
1/31/2026 - Tickeron - Stocks
NeoGenomics (NEO, $12.06) price may climb as it broke lower Bollinger Band on Jan 30, 2026
1/31/2026 - Tickeron - Stocks
Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), NeoGenomics (NEO)
1/29/2026 - TipRanks Financial Blog
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Analysts
1/29/2026 - MarketBeat
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
1/27/2026 - GuruFocus
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
1/27/2026 - Business Wire
Assessing NeoGenomics (NEO) Valuation After New 2025 Guidance And CFO Transition
1/26/2026 - Simply Wall St
NeoGenomics: Distribution Moat In Community Oncology
1/25/2026 - SeekingAlpha
NeoGenomics: Distribution Moat In Community Oncology
1/25/2026 - Seeking Alpha - Long Ideas
Should NeoGenomics' CFO Transition and Early 2025 Revenue Signals Require Action From NEO Investors?
1/25/2026 - Simply Wall St
Guardant Health, Jabil, NeoGenomics, Darden, Cormedix Insider Moves
1/24/2026 - TipRanks Financial Blog
NeoGenomics (NEO, $12.81) entered Downtrend as Momentum indicator drops below 0 level on Jan 23, 2026
1/24/2026 - Tickeron - Technical Analysis
Don't Ignore The Insider Selling In NeoGenomics
1/23/2026 - Simply Wall St
NeoGenomics (NEO, $12.69) entered Downtrend as Momentum indicator drops below 0 level on Jan 21, 2026
1/22/2026 - Tickeron - Stocks
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays
5/6/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$709.16M
EBITDA (TTM)
-$12.83M
EBIT (TTM)
-$82.44M
Net Income (TTM)
-$113.47M
Balance Sheet
Total Assets (Q)
$1.37B
Total Debt (Q)
$410.31M
Total Liabilities (Q)
$536.49M
Book Value Per Share (Q)
$6.50
Cash Flow
Cash from Operations (TTM)
$13.69M
Cash from Investing (TTM)
-$11.50M
Cash from Financing (TTM)
-$200.03M
Net Change in Cash (TTM)
-$197.88M
Filings
Filing Date
Tuesday, October 28, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.17
7-Day Total Return
-4.93%
30-Day Total Return
-3.23%
60-Day Total Return
11.35%
90-Day Total Return
25.05%
Year to Date Total Return
-3.23%
1-Year Total Return
-18.19%
2-Year Total Return
-20.42%
3-Year Total Return
-10.60%
5-Year Total Return
-80.80%
52-week Low
Aug 01, 2025 - $4.72
52-week High
Feb 14, 2025 - $14.73
Valuation
Market Cap
$1.45B - Small Cap
Enterprise Value
$1.69B
Price/Sales (TTM)
2.02
Price/Book (Q)
1.72
Dividends and Shares
Shares Outstanding
128.42M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.neogenomics.com
Phone Number
239 768 0600
Address
9490 NeoGenomics Way
Fort Myers, FL 33912
Country
United States
Year Founded
2001
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced... more
NASDAQ 02/13/2026 4:00PM Eastern Quotes delayed